Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5- CLL

Leukemia Research

Volumn 26, Issue 12, 2002, Pages 1125-1129

  Wang, Chen ^a   Amato, Dominick ^a   Rabah, Rola ^a   Zheng, Jianing ^a   Fernandes, Bernard ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

CD5 ; CLL; Clonal lymphocytosis of unknown significance; MLUS; Phenotype; Variant CLL; Weak CD5

Indexed keywords

CD5 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMATOLOGY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIXED TUMOR; MONOCLONAL B LYMPHOCYTOSIS OF UNDETERMINED SIGNIFICANCE; PHENOTYPE; PRIORITY JOURNAL; PROLYMPHOCYTIC LEUKEMIA; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD5; B-LYMPHOCYTES; CLONE CELLS; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOCYTOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0036890038     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(02)00062-0     Document Type: Article

References (17)

1. Rozman C., Montserrat E. Chronic lymphocytic leukemia. New Engl. J. Med. 333:1995;1052.
2. Cheson B.D., Bennett J.M., Grever M., Kay N., Keating M.J., O'Brien S.et al. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood. 87:1996;4990.
3. Kilo M.N., Dorfman D.M. The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma/chronic lymphocytic leukemia from mantle cell lymphoma. Am. J. Clin. Pathol. 105:1996;451.
4. Geisler C.H., Larson J.K., Hansen N.E., Hansen N.M., Christensen B.E., Lund B.et al. Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood. 78:1991;1795.
5. Faguet G.B., Agee J.F., Marti G.E. CD5 and cCLLA expression in chronic lymphocytic leukemia (CLL): demonstration of their relative prevalence and that of other common B-cell markers. Leuk. Lymphoma. 6:1992;335.
6. Kurec A.S., Threatte G.A., Gottlieb A.J., Smith J.R., Anderson J., Davey F.R. Immunophenotypic subclassification of chronic lymphocytic leukemia (CLL). Br. J. Haematol. 81:1992;45.
7. + B CLL and B PLL. Leuk. Lymphoma. 16:1995;445.
8. Cartron G., Linassier C., Bremond L., Desablens B., Georget M.T., Fimbel B.et al. CD5 negative B-cell chronic lymphocytic leukemia: clinical and biological features of 42 cases. Leuk. Lymphoma. 31:1998;209.
9. - B-cell lymphoproliferative disorders presenting in blood. Am. J. Clin. Pathol. 111:1995;477.
10. Bennett J.M., Catovsky D., Daniel M.T., Flanderin G., Carton D.A.G., Gralnick H.R.et al. The French-American-British (FAB) cooperative group: proposals for the classification of chronic (mature) B and T lymphoid leukemias. J. Clin. Pathol. 42:1989;567.
11. - small B-cell leukemias are rarely classifiable as chronic lymphocytic leukemia. Am. J. Clin. Pathol. 111:1999;123.
12. Kay N.E., Peterson L. Heterogeneity of CD5 membrane expression on B-chronic lymphocytic leukemia cells. Leuk. Lymphoma. 5:1991;49.
13. Kimby E., Mellstedt H., Nilsson B., Bjorkholm M., Holm G. Differences in blood T and NK cell populations between chronic lymphocytic leukemia of B cell type and monoclonal B-lymphocytosis of undetermined significance (B-MLUS). Leukemia. 3:1989;501.
14. Garcia C., Rosen A., Kimby E., Aguilar-Santelises M., Jondal M., Bjorkhilm M.et al. Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia as compared to monoclonal B-cell lymphocytosis of undetermined significance. Leuk. Res. 13:1989;31.
15. Han T., Ozer H., Gavigan M., Gajera R., Minowada J., Bloom M.L.et al. Benign monoclonal B cell lymphocytosis - a benign variant of CLL: clinical, immunologic, phenotypic and cytogenetic studies in 20 patients. Blood. 64:1984;244.
16. Aman P., Mellstedt H. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population. Leuk. Res. 15:1991;715.
17. Garcia C., Rosen A., Aguilar-Santelises M., Jondal M., Mellstedt H. Higher proliferative response in B-chronic lymphocytic leukemia (B-CLL) as compared to B-monoclonal lymphocytosis of undetermined significance (B-MLUS) after stimulation with staphylococcus aureus and anti-CD40 monoclonal antibodies. Leuk. Res. 17:1993;933.